Welcome to Connect, @jelrog.
At Mayo Clinic, research is leading the development of new regenerative therapies (stem cell therapies) for people with a wide range of lung diseases. Regenerative medicine has the potential to provide innovative new therapies for people with lung diseases, including chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, cystic fibrosis, pulmonary arterial hypertension and bronchiolitis obliterans. You can read more about it here: http://mayocl.in/2ieWfYH

I'm tagging @mike0m @pd02 and @powderpuf as they too were looking into stem cell therapy and pulmonary fibrosis.
Jelrog, how are you currently managing IPF?